Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changtong Oral Liquid for Prevention of Postoperative Peritoneal Adhesions
CTR20170198Phase 2Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Changtong Oral Liquid in Peritoneal adhesions (ARD), acute appendicitis, chronic appendicitis, Fibromyoma (LM), cholecystitis, sponsored by Nanfang Hospital, Southern Medical University. Started Mar 2017; status: completed.
02
Drugs
Changtong Oral Liquid
03
Conditions
Peritoneal adhesions (ARD)acute appendicitischronic appendicitisFibromyoma (LM)cholecystitis
Beyond the preview
Go deeper on CTR20170198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170198.